The Copyright policy demonstrates the rights related to the publication and distribution of a submitted article. It governs how authors (as well as their employers or funders), publishers and the wider general public can use, publish and distribute the articles. Copyright aims to protect the specific way the article has been written to describe an experiment and the results. International Journal of Immunotherapy and Cancer Research (IJICR) is committed to its authors to protect and defend their work and their reputation and takes allegations of infringement, plagiarism, ethic disputes and fraud very seriously.
The copyright on any open access article in IJICR is retained by the author(s). Authors identify themselves as original publishers and provide a cover letter with a declaration that they are granting permission to IJICR to publish their articles.
The copyright policy allows the authors to grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. These terms and conditions of published articles are according to The Creative Commons Attribution License 4.0.
In case an author is prevented from being a copyright holder due to some government led regulations or any other circumstances, the authors should inform IJICR during or immediately after submission of their article. Once the article is published, claims for changes in copyright line cannot be entertained.
If you have any other query related to copyright policy, Please write to michael.j@peertechz.info or info@peertechz.com
PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."